Crescent Biopharma Ownership | Who Owns Crescent Biopharma?

Overview Forecast RevenueFinancials Chart

Crescent Biopharma Ownership Summary

Crescent Biopharma is owned by 24.04% institutional investors, 5.81% insiders, and 70.15% retail investors. Fmr is the largest institutional shareholder, holding 3.97% of CBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Crescent Biopharma shares.

CBIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Crescent Biopharma	24.04%	5.81%	70.15%
Sector	Healthcare Stocks	35.42%	11.83%	52.76%
Industry	Biotech Stocks	35.46%	11.78%	52.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	4.13M	3.97%	$75.93M
Bvf inc/il	2.75M	2.64%	$50.49M
Fairmount funds management	2.75M	2.64%	$50.48M
Vr adviser	2.13M	2.05%	$39.19M
Fcpm iii services b.v.	1.68M	1.61%	$30.82M
Balyasny asset management	1.51M	1.45%	$27.74M
Vestal point capital, lp	1.50M	1.44%	$27.55M
Opaleye management	1.31M	1.26%	$24.11M
Tang capital management	1.16M	1.11%	$21.31M
Logos global management lp	482.50K	0.46%	$8.86M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fcpm iii services b.v.	1.68M	4.27%	$30.82M
Fairmount funds management	2.75M	3.65%	$50.48M
Opaleye management	1.31M	3.18%	$24.11M
Bvf inc/il	2.75M	1.61%	$50.49M
Vr adviser	2.13M	1.46%	$39.19M
Exome asset management	153.19K	1.46%	$2.81M
Tang capital management	1.16M	1.08%	$21.31M
Vestal point capital, lp	1.50M	0.77%	$27.55M
Stonepine capital management	85.00K	0.63%	$1.56M
Logos global management lp	482.50K	0.44%	$8.86M

Top Buyers

Holder	Shares	% Assets	Change
Balyasny asset management	1.51M	0.04%	1.40M
Tang capital management	1.16M	1.08%	287.60K
Millennium management	323.55K	0.00%	261.67K
Goldman sachs group	228.47K	0.00%	203.23K
Marshall wace, llp	200.78K	0.00%	178.95K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-642.72K
Boxer capital management	-	-	-453.69K
Driehaus capital management	-	-	-302.46K
Frazier life sciences management	-	-	-272.95K
Heights capital management	-	-	-264.00K

New Positions

Holder	Shares	% Assets	Change	Value
Exome asset management	153.19K	1.46%	153.19K	$2.81M
Jennison associates	152.97K	0.00%	152.97K	$2.81M
Silverarc capital management	130.50K	0.24%	130.50K	$2.40M
Hudson bay capital management lp	88.87K	0.01%	88.87K	$1.63M
Vanguard fiduciary trust	49.42K	0.00%	49.42K	$907.90K

Sold Out

Holder	Change
Group one trading	-4.00
Raymond james financial	-50.00
Tower research capital llc (trc)	-409.00
Hrt financial lp	-13.08K
Affinity asset advisors	-18.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	58	7.41%	25,034,144	5.44%	24	3.52%	33	-10.81%	7	-22.22%
Dec 31, 2025	11	-72.50%	904,390	-92.01%	-	634.79%	5	-77.27%	5	-37.50%
Sep 30, 2025	7	-75.86%	837,114	-92.21%	-	27.94%	5	-82.76%	1	-
Jun 30, 2025	29	-	10,751,740	-	1,244	-	29	-	-	-
Dec 31, 2024	1	-	15	-	-	-	1	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	698.85K	2.53%	-
Fidelity Growth Compy Commingled Pl S	432.75K	1.57%	676.00
Fidelity Growth Company Fund	292.68K	1.06%	-
Fidelity Advisor Biotechnology I	251.09K	0.91%	-
T. Rowe Price Health Sciences	221.06K	0.80%	-10.50K
Fidelity Select Biotechnology	113.42K	0.41%	-
Fidelity Growth Company K6	103.83K	0.38%	-676.00
Vanguard Institutional Extnd Mkt Idx Tr	84.10K	0.30%	2.17K
Fidelity Series Growth Company	69.19K	0.25%	-
Fidelity Extended Market Index	45.52K	0.17%	5.50K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 04, 2025	Fairmount Funds Management LLC		Buy	$18.24M
Dec 04, 2025	Fairmount Funds Management LLC		Buy	$131.43
Aug 07, 2024	Invus Public Equities, L.P.	-	Sell	$11.20K
Aug 08, 2024	Invus Public Equities, L.P.	-	Sell	$50.01K
Aug 06, 2024	Invus Public Equities, L.P.	-	Sell	$10.19K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	2	-
2025 Q3	-	-
2025 Q2	-	-

CBIO Ownership FAQ

Who Owns Crescent Biopharma?

Crescent Biopharma shareholders are primarily institutional investors at 24.04%, followed by 5.81% insiders and 70.15% retail investors. The average institutional ownership in Crescent Biopharma's industry, Biotech Stocks , is 35.46%, which Crescent Biopharma falls below.

Who owns the most shares of Crescent Biopharma?

Crescent Biopharma’s largest shareholders are Fmr (4.13M shares, 3.97%), Bvf inc/il (2.75M shares, 2.64%), and Fairmount funds management (2.75M shares, 2.64%). Together, they hold 9.25% of Crescent Biopharma’s total shares outstanding.

Does Blackrock own Crescent Biopharma?

BlackRock is not among the top 10 institutional shareholders of Crescent Biopharma.

Who is Crescent Biopharma’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Crescent Biopharma’s biggest shareholder by percentage of total assets invested, with 4.27% of its assets in 1.68M Crescent Biopharma shares, valued at 30.82M$.

Who is the top mutual fund holder of Crescent Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Crescent Biopharma shares, with 2.53% of its total shares outstanding invested in 698.85K Crescent Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools